A Japanese health ministry proposal to impose steeper price cuts on certain medicines deemed to carry poor cost-effectiveness profiles cleared…
HOME > REGULATORY
REGULATORY
- MHLW Budget Request Includes Funds for Database of Information on Patients with Cancer, Lifestyle Diseases
September 18, 2012
- MHLW Calls for Self-Inspections at Japanese Pharmaceutical Firms after “Gutter Oil”-Made Antibiotic Intermediates Found in China
September 14, 2012
- MHLW Instructs Daiichi Sankyo to Issue Blue Letter on Ranmark Following Two Reported Deaths
September 13, 2012
- MEXT Calls for 21 Billion Yen for Special Priority Area of Healthcare Innovation in FY2013 Budget Request
September 12, 2012
- Osaka District Court to Issue Ruling on Actos Patent Suit on Sept. 27
September 12, 2012
- MHLW Issues Q&As on Drug Risk Management Plans to Prefectures
September 12, 2012
- MHLW Notifies of Expected Additional Indications for 3 APIs
September 12, 2012
- PAFSC’s 2nd Committee Designates 7 products as Orphan Drugs Including Glioblastoma Treatment Bevacizumab
September 11, 2012
- Chairman Breaks Tie, Votes to Continue Lower House Discussions on Bill to Establish 3rd-Party Organization
September 11, 2012
- MHLW’s FY2013 Budget Request Includes Funding to Set Up Municipal Generic Drug Promotion Councils
September 11, 2012
- PAFSC 2nd Committee Recommends Approval for Novartis’s COPD Drug
September 11, 2012
- DPJ’s Project Team Concerned that Participation in TPP Agreement Could Interfere with Japan’s Industrial Policies
September 10, 2012
- MHLW to Study Overseas Generic Drug Markets to Support Globalization of Domestic Industry
September 10, 2012
- “Some Problems” Found with UMN Pharma’s Cell Culture Method Development Project: MHLW
September 7, 2012
- Labor Standards Bureau Head Junichi Kaneko to Be Appointed Vice Minister of Health; Pension Bureau Head Jun Ebata to Be Transferred to PFSB: MHLW
September 6, 2012
- MHLW to Request 41.1 Bil. Yen in FY2013 Budget for Drug Discovery Support and Other Special Priority Projects
September 6, 2012
- Project to Develop Vaccines for New Influenza Strains Using Chicken Egg Culture Method Receives “A” Grade: MHLW
September 4, 2012
- 3 Generics with 2 APIs Found to Be Non-Compliant in FY2011 Quality Assurance Project: MHLW
September 4, 2012
- PAFSC’s 1st Committee Recommends Approval for Bayer Yakuhin’s AMD Drug
September 3, 2012
- JPWA, NPhA Confirm Further Efforts Needed to Increase Awareness among Members Amid Lag in Distribution Improvements
September 3, 2012
ページ
A Japanese drug pricing panel on November 11 discussed ways to respond to the US most-favored-nation (MFN) policy, with healthcare…
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Japan is set to add 16 new drugs to its NHI reimbursement price list on November 13, including a subcutaneous…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…